Speaker(s): 

Akanksha Sharma, MD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Mark Karcutskie, MD, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the completion of this course, the participant should be able to:

• Discuss guidelines for education on terminology and pharmacology associated with cannabinoid therapy in the perioperative period.
• Recognize clinical implications, addressing evidence-based aspects and knowledge gaps associated with cannabinoids in the perioperative period.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Matthew Desciak, MD, Mark Karcutskie, MD, William Cooper, CRNA, Lorraine Kuchta and Colleen Lear have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.